Spots Global Cancer Trial Database for first line therapy
Every month we try and update this database with for first line therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma | NCT02247869 | Hodgkin Lymphom... | dose dense ABVD | 18 Years - 70 Years | Fondazione Italiana Linfomi - ETS | |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma | NCT02247869 | Hodgkin Lymphom... | dose dense ABVD | 18 Years - 70 Years | Fondazione Italiana Linfomi - ETS | |
| Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC. | NCT02405910 | Non-small Cell ... | Nab-paclitaxel Gemcitabine | 18 Years - | West Virginia University | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC. | NCT02405910 | Non-small Cell ... | Nab-paclitaxel Gemcitabine | 18 Years - | West Virginia University | |
| Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer | NCT00976456 | Non-squamous No... | Bevacizumab + P... Bevacizumab + P... | 65 Years - | Martha-Maria Krankenhaus Halle-Dölau gGmbH | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients | NCT01641783 | Gastric Adenoca... | nanoparticle Al... | 18 Years - 75 Years | The Third Affiliated Hospital of Harbin Medical University | |
| Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00044291 | Breast Neoplasm... Neoplasms, Horm... | atamestane toremifene letrozole aromatase inhib... hormone therapy endocrine thera... antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer | NCT01567618 | Gastric Adenoca... | Docetaxel Fluorouracil | 18 Years - 80 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects | NCT03631199 | Non-small Cell ... | canakinumab canakinumab mat... pembrolizumab carboplatin cisplatin paclitaxel nab-paclitaxel pemetrexed | 18 Years - | Novartis | |
| Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | NCT00267553 | Breast Neoplasm... Neoplasms, Horm... | Atamestane toremifene letrozole | 18 Years - | Intarcia Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
